Portfolio

Promatix

Promatix is an ALSA Group comany using multi-omic insights to develop the next generation of cancer therapeutics

Visit Website
Montis Biosciences

Develops novel immuno-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumors

Visit Website
Epsilogen

World leader in IgE drugs with a pipeline of therapies to treat solid cancer tumours

Visit Website
Oxford BioTherapeutics

Pipeline of first in class oncology drugs leveraging a proprietary database

Visit Website